Bellerophon Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2013 to 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Bellerophon Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2022.
  • Bellerophon Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2023 was -$2.17M, a 57.6% increase year-over-year.
  • Bellerophon Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2023 was -$11M, a 48.8% increase year-over-year.
  • Bellerophon Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$22.4M, a 11% decline from 2021.
  • Bellerophon Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$20.2M, a 23.3% increase from 2020.
  • Bellerophon Therapeutics, Inc. annual Operating Income (Loss) for 2020 was -$26.3M, a 50.4% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$22.4M -$2.22M -11% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-31
2021 -$20.2M +$6.12M +23.3% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$26.3M -$8.8M -50.4% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-31
2019 -$17.5M +$10.4M +37.3% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-31
2018 -$27.9M -$3.28M -13.3% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-11
2017 -$24.6M -$842K -3.54% Jan 1, 2017 Dec 31, 2017 10-K 2020-04-06
2016 -$23.8M +$22.8M +49% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-14
2015 -$46.6M +$13.2M +22.1% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-15
2014 -$59.8M +$2.25M +3.62% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-13
2013 -$62M Jan 1, 2013 Dec 31, 2013 10-K 2016-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.